@article{8083ba3531134d0bad894f899b936f51,
title = "International task force on benzodiazepines",
author = "Richard Balon and Guy Chouinard and Fiammetta Cosci and Dubovsky, \{Steven L.\} and Fava, \{Giovanni A.\} and Freire, \{Rafael C.\} and Greenblatt, \{David J.\} and Krystal, \{John H.\} and Nardi, \{Antonio E.\} and Karl Rickels and Thomas Roth and Carl Salzman and Richard Shader and Silberman, \{Edward K.\} and Nicoletta Sonino and Vladan Starcevic and Weintraub, \{Steven J.\}",
note = "Funding Information: Dr. Krystal reports the following support. Sources of research support: Department of Veterans Affairs, VA National Center for PTSD; Department of Veterans Affairs/Department of Defense, Consortium for Alleviation of PTSD; National Center for Advancing Translational Science, NIH; National Institute on Alcohol Abuse and Alcoholism, P50 (CTNA); National Institute of Mental Health, FAST-Psychosis Consortium. Paid editorial relationship: Biological Psychiatry (editor). Scientific advisory boards: biOasis Technologies Inc., Biohaven Pharmaceuticals; Blackthorn Therapeutics Inc.; Broad Institute at MIT and Harvard; Lohocla Research Corporation; Luc Therapeutics Inc.; Pfizer Pharmaceuticals; TRImaran Pharma. Stocks: ArNETT Neuroscience Inc.; Bio-haven Medical Sciences; Blackthorn Therapeutics Inc.; Spring Care Inc. Stock options: Biohaven Pharmaceuticals Medical Sciences; Luc Therapeutics Inc. Consulting relationships: AstraZen-eca Pharmaceuticals; Biogen, Idec, MA; Biomedisyn Corporation; Janssen Research \& Development; L.E.K. Consulting; Otsuka America Pharmaceuticals Inc.; Pragma Therapeutics; S K Life Science; Spring Care Inc.; Sunovion Pharmaceuticals Inc.; Takeda Industries; Taisho Pharmaceuticals Co. Ltd; Teva Branded Pharmaceutical Products R\&D Inc. Patents: Dopamine and Noradrenergic Reuptake Inhibitors in Treatment of Schizophrenia; Glutamate Modulating Agents in the Treatment of Mental Disorders; Intranasal Administration of Ketamine to Treat Depression; Methods of Treating Suicidal Ideation. Provisional patents: Composition and Method to Treat Addiction; Treatment Selection for Major Depressive Disorder; Compounds Compositions and Methods for Treating or Preventing Depression and Other Diseases. Speaker{\textquoteright}s Bureau: None.",
year = "2018",
month = aug,
day = "1",
doi = "10.1159/000489538",
language = "English",
volume = "87",
pages = "193--194",
journal = "Psychotherapy and Psychosomatics",
issn = "0033-3190",
number = "4",
}